A recent study published in the journal Health Economics finds that state-level marijuana legalization correlates with a reduction in prescription drug spending among privately insured working-age adults. Researchers from Bowling Green State University and Illinois State University examined the effects of marijuana legalization laws on prescription drug expenditures.
The study revealed notable declines in prescription drug costs specifically among enrollees of small group insurance plans, which are typically provided by employers with fewer than 50 employees. However, no similar reductions were observed in large group insurance plans. The researchers suggested that this disparity may be due to larger companies often implementing mandatory marijuana testing for employees, which could limit access to cannabis for their workforce.
The authors stated, “Recreational cannabis laws result in relative declines in prescription drug claims that are concentrated in small group insurance markets.” They noted that the legalization of cannabis may offer an alternative to conventional prescription medications and support overall health maintenance.
These findings align with previous research indicating that marijuana legalization is linked to lower health care premiums and decreased Medicaid spending. Paul Armentano, Deputy Director of the National Organization for the Reform of Marijuana Laws (NORML), commented on the implications of the data, stating that cannabis has proven effective for treating various conditions, including chronic pain, and has a safety profile that can rival or exceed that of many prescription drugs, such as opioids.
As access to legal cannabis continues to broaden, it is anticipated that more patients will incorporate cannabis products into their health management strategies, potentially reducing their reliance on traditional prescription medications.
The full study, titled “The effects of medical and recreational cannabis laws on prescription drug claims in commercial group insurance markets,” is available in Health Economics. Additional resources regarding the relationship between cannabis and prescription drugs can be found in the NORML Fact Sheet, ‘Relationship Between Marijuana and Opioids.’
English 
Spanish 
German 
Czech